While the Stamford, Conn.-based company has acknowledged in the United States that its marketing of the drug was misleading, it has not made a similar admission in Canada
While the Stamford, Conn.-based company has acknowledged in the United States that its marketing of the drug was misleading, it has not made a similar admission in Canada